Your browser doesn't support javascript.
loading
Safety study of lazabemide (Ro19-6327), a new MAO-B inhibitor, on cardiac arrhythmias and blood pressure of patients with Parkinson's disease.
Narabayashi, H; Yamaguchi, T; Sugi, K; Mitamura, H; Mizuno, Y; Nakashima, M.
Affiliation
  • Narabayashi H; Neurological Clinic, Toho University, Ohashi Hospital, Japan.
Clin Neuropharmacol ; 22(6): 340-6, 1999.
Article in En | MEDLINE | ID: mdl-10626094
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Picolinic Acids / Arrhythmias, Cardiac / Blood Pressure / Monoamine Oxidase / Monoamine Oxidase Inhibitors / Antiparkinson Agents Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Neuropharmacol Year: 1999 Document type: Article Affiliation country: Japan Country of publication: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Picolinic Acids / Arrhythmias, Cardiac / Blood Pressure / Monoamine Oxidase / Monoamine Oxidase Inhibitors / Antiparkinson Agents Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Neuropharmacol Year: 1999 Document type: Article Affiliation country: Japan Country of publication: United States